The promising medication, Retatrutide, is creating growing excitement in the country regarding a potential solution for weight loss. Developed by Eli Lilly, it combines the actions of two GLP-1 receptor agonists and an glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, trying to more effectively impact food intake and improve e… Read More